The largest database of trusted experimental protocols

Gentamicin

Manufactured by B. Braun
Sourced in Germany

Gentamicin is a broad-spectrum antibiotic used for the treatment of various bacterial infections. It functions by inhibiting the synthesis of bacterial proteins, thereby preventing the growth and replication of the bacteria.

Automatically generated - may contain errors

2 protocols using gentamicin

1

Monocyte-derived Dendritic Cell Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to obtain human monocytes, PBMCs were cultured in a 75 cm2 cell culture flask for 2 h at 37 °C in a 5% CO2 environment at a concentration of 3–4 × 106 cells/mL in X-VIVO 15 media (Lonza, MD, USA) supplemented with 1% inactivated autologous serum, gentamicin (50 μg/mL, B/Braun Medical, Melsungen, Germany), fungizone (2.5 μg/mL, Life Technologies, California, USA), and Zidovudine (1μM, Genéricos Españoles Laboratorios, Madrid, Spain). Monocytes were confirmed to be in a monolayer after incubation for 2 h, and the nonadherent cells (MNC) were removed by three washes with phosphate-buffered saline (PBSx1) (Figure S1). Subsequently, monocytes were cultured for 6 days with 1000 U/mL each of recombinant human IL-4 (ProSpec, Rehovot, Israel) and recombinant human GM-CSF (ProSpec) on days 0 and 2. After 6 days, immature dendritic cells (iDCs) were obtained by adding cold PBSx1 to the 75 cm2 cell culture flask to the harvest them by firmly tapping the flasks. This dislodged the loosely adherent dendritic cell (DC) clusters. MDDCs were harvested into a 50 mL conical tube and counted manually for viability using the trypan blue exclusion dye. Lymphocytes were collected from MNC fractions and frozen as PBMCs for use in mixed lymphocyte response assays across different DC preparations.
+ Open protocol
+ Expand
2

Generation of Monocyte-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After isolation, PBMCs were immediately cultured in a T75 flask for 2 h at 37 °C in a humidified air 5% CO2 atmosphere at a concentration of 3–4 × 106 cells/mL in X-VIVO 15 media (Lonza, Basel, Switzerland), supplemented with 1% human AB serum (Sigma-Aldrich), 50 μg/mL gentamicin (B/Braun Medical, Melsungen, Germany) and 2.5 μg/mL amphotericin B (fungizone; Bristol-MyersSquibb, Rueil-Malmaison, France). After 2 h of incubation, monocytes were observed as adherent cells and nonadherent cells were removed by three washes with PBS 1X. Subsequently, 1000 U/mL each of human recombinant IL-4 and GM-CSF (both from ProSpec, Rehovot, Israel) were added to monocytes (days 0 and 2) and after 5 days the immature MDDCs were obtained and washed with cold PBS 1X.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!